AB SCIEX has been launched as a new company dedicated to life science analytical technologies. The new company is formed from the combination of the two halves of the AB SCIEX mass spectrometry joint venture.
AB SCIEX has been launched as a new company dedicated to life science analytical technologies. The new company is formed from the combination of the two halves of the AB SCIEX mass spectrometry joint venture.
“This integrated company will be able to shape the future of mass spectrometry in ways far greater than what we have already achieved,” said Laura Lauman, the company’s president, in a statement. According to Lauman, bringing the former joint venture together will enable the company to “keep pace with the dynamic needs of the life science industry.”
The company provides instrumentation, software and services used in a number of life science applications, including drug discovery and development, disease studies and food and environmental safety. These include integrated LC–MS–MS platforms for small molecule analysis, contaminant identification and biomarker validation, as well as MALDI TOF/TOF systems for protein biomarker discovery.
For more information about the company go to www.absciex.com
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Using Chromatography to Explore Fluorescent Bioactive Compounds in the Coelomic Fluid of Earthworms
February 6th 2025A study aiming to identify fluorescent bioactive compounds in the coelomic fluid of earthworms, as well as to investigate their structural and functional characteristics for possible use in biomedical applications, utilized a variety of chromatographic techniques.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.